The ‘Darzi Collaborative’: Why the AAC’s new Chair will give it some much-needed impetus

Today it was confirmed Lord Darzi will replace Sir Andrew Witty as Chair of the Accelerated Access Collaborative (AAC). Led by NICE and drawing together 13 government departments, regulatory bodies and industry representatives, the AAC is tasked with “making the process of getting transformative technologies to patients quicker, cheaper and easier for innovators and theRead more

Mental health: Keeping the future in mind

The public’s understanding of, and interest in, mental health has never been greater, something to be encouraged and acted upon. However, awareness doesn’t necessarily translate into the concrete policy change needed to improve such vital services. This week is Mental Health Awareness week, providing a perfect opportunity to reflect and take stock of the progressRead more

Drugpolitik: Trump’s pharma trade war puts medicines in the Brexit spotlight

Eighteen months into his Presidency, Donald Trump has finally found a saleable enemy for America’s high medical bills: ‘freeloading foreign governments.’ Healthcare costs often poll as one of the leading concerns of U.S. citizens, but Trump hasn’t been able to conjure a bogeyman who doesn’t infringe on the low-regulation, low-tax mantra of America First. UntilRead more

Facing the Change: What the Future Operating Model Means for Hospital Suppliers

NHS procurement is proving to be the ultimate rubix cube for policymakers tasked with knocking hundreds of millions of pounds from NHS spending figures. Despite progress being made towards Lord Carter’s vision for operational productivity – with news last week that the NHS Business Services Authority and NHS Supply Chain have met £300 million cash-releasingRead more

Hitting the target: where now for precision medicines?

Today (10th April 2018) WA Health has launched a new insight report on precision medicines, Hitting the target: Where now for precision medicines? In recent years precision medicines have become increasingly common as our understanding of disease, particularly cancer, has become more advanced. For example, lung cancer, once described as a single disease, is nowRead more

8 things you need to know about NICE’s changes to its appraisal process

The National Institute for Health and Care Excellence (NICE) has this week published its updated guide to its health technology appraisal (HTA) process following two rounds of consultations over the last six months. The aim of these changes is to streamline and accelerate the appraisal process. This consultation process has been very low key andRead more